Isolation of tetracycline-resistant Chlamydia suis from a pig herd affected by reproductive disorders and conjunctivitis by Unterweger, Christine et al.








Isolation of tetracycline-resistant Chlamydia suis from a pig herd affected by
reproductive disorders and conjunctivitis
Unterweger, Christine ; Schwarz, Lukas ; Jelocnik, Martina ; Borel, Nicole ; Brunthaler, René ;
Inic-Kanada, Aleksandra ; Marti, Hanna
Abstract: Due to various challenges in diagnosing chlamydiosis in pigs, antibiotic treatment is usually
performed before any molecular or antibiotic susceptibility testing. This could increase the occurrence
of tetracycline-resistant Chlamydia (C.) suis isolates in the affected pig population and potentiate the
reoccurrence of clinical signs. Here, we present a case of an Austrian pig farm, where tetracycline resistant
and sensitive C. suis isolates were isolated from four finishers with conjunctivitis. On herd-level, 10% of
the finishers suffered from severe conjunctivitis and sows showed a high percentage of irregular return
to estrus. Subsequent treatment of whole-herd using oxytetracycline led to a significant reduction of
clinical signs. Retrospective antibiotic susceptibility testing revealed tetracycline resistance and decreased
susceptibility to doxycycline in half of the ocular C. suis isolates, and all isolates were able to partially
recover following a single-dose tetracycline treatment in vitro. These findings were later confirmed in
vivo, when all former clinical signs recurred three months later. This case report raises awareness of
tetracycline resistance in C. suis and emphasizes the importance of preventative selection of tetracycline
resistant C. suis isolates.
DOI: https://doi.org/10.3390/antibiotics9040187






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Unterweger, Christine; Schwarz, Lukas; Jelocnik, Martina; Borel, Nicole; Brunthaler, René; Inic-Kanada,
Aleksandra; Marti, Hanna (2020). Isolation of tetracycline-resistant Chlamydia suis from a pig herd




Isolation of Tetracycline-Resistant Chlamydia suis
from a Pig Herd Affected by Reproductive Disorders
and Conjunctivitis
Christine Unterweger 1,* , Lukas Schwarz 1 , Martina Jelocnik 2 , Nicole Borel 3,
René Brunthaler 4, Aleksandra Inic-Kanada 5 and Hanna Marti 3
1 Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of
Veterinary Medicine, 1210 Vienna, Austria
2 Genecology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD 4556, Australia
3 Institute of Veterinary Pathology, Vetsuisse Faculty University Zurich, 8057 Zurich, Switzerland
4 Institute of Pathology, Department of Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria
5 Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, 1090 Vienna, Austria
* Correspondence: christine.unterweger@vetmeduni.ac.at
Received: 21 March 2020; Accepted: 14 April 2020; Published: 17 April 2020


Abstract: Due to various challenges in diagnosing chlamydiosis in pigs, antibiotic treatment is
usually performed before any molecular or antibiotic susceptibility testing. This could increase the
occurrence of tetracycline-resistant Chlamydia (C.) suis isolates in the affected pig population and
potentiate the reoccurrence of clinical signs. Here, we present a case of an Austrian pig farm, where
tetracycline resistant and sensitive C. suis isolates were isolated from four finishers with conjunctivitis.
On herd-level, 10% of the finishers suffered from severe conjunctivitis and sows showed a high
percentage of irregular return to estrus. Subsequent treatment of whole-herd using oxytetracycline
led to a significant reduction of clinical signs. Retrospective antibiotic susceptibility testing revealed
tetracycline resistance and decreased susceptibility to doxycycline in half of the ocular C. suis isolates,
and all isolates were able to partially recover following a single-dose tetracycline treatment in vitro.
These findings were later confirmed in vivo, when all former clinical signs recurred three months later.
This case report raises awareness of tetracycline resistance in C. suis and emphasizes the importance
of preventative selection of tetracycline resistant C. suis isolates.
Keywords: Chlamydia suis; fertility problems; conjunctivitis; minimal inhibition concentration;
multilocus sequence typing; recovery testing; tetracycline resistance
1. Introduction
Chlamydial infections have been associated with a variety of diseases in pigs [1], including
conjunctivitis [2,3], pneumonia [4], enteritis [5,6], and polyarthritis [7]. Additionally, Chlamydia spp.
can cause a wide range of reproductive disorders such as abortions [8], perinatal mortality [9], vaginal
discharge, repeated breeding [10,11], as well as poor reproductive performances in sows [12]. Chlamydia
(C.) suis is the most prevalent chlamydial species in pigs [1,13]. The diagnosis of Chlamydiaceae
infections, in particular, antibiotic susceptibility testing, is time-consuming and laborious due to
their obligate intracellular nature. For diagnosing chlamydial infections in veterinary medicine,
open questions containing the sampling type and timing, depend on the animal host species, clinical
signs, or anatomical localization to test. Moreover, only few laboratories can offer the cultivation of
these bacteria, restricting diagnosis to molecular methods, and thus any statement regarding their
growth characteristics, virulence, and antibiotic resistance patterns will be missing [14]. Detecting
evidence for the involvement of C. suis in the pathogenesis of fertility problems in sows is especially
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challenging. Therefore, C. suis infections are often diagnosed clinically following the exclusion of other
well-known pathogens, but without the detection of C. suis using either nucleic acid amplification
tests (NAATs) or serological methods, and without the identification of chlamydial inclusions using
immunohistochemical or immunofluorescence staining [15]. Cultivation of these obligate intracellular
bacteria is very laborious and expensive. Consequently, antibiotic susceptibility testing, which requires
cell culture systems, is not performed on a routine basis.
Following the diagnosis of chlamydial infections in veterinary medicine, in the absence of an
effective anti-C. suis vaccine, tetracyclines are usually the treatment of choice [15]. Tetracyclines are
easy to apply via food or water. They are not on the WHO list of critically important antimicrobials [16]
in contrast to macrolides, which are the treatment of choice in human chlamydial infections. In pigs,
this could be a cause for concern considering that C. suis is the only chlamydial species known to
have naturally acquired genes that encode tetracycline resistance [17,18]. Moreover, there is evidence
for intra- and interspecies recombination upon co-infection in vitro such as tetA(C) transfer among
C. suis isolates, as well as from C. suis to C. trachomatis [19,20]. All of these factors might have severe
consequences for human health, considering that both C. suis and C. trachomatis DNA have been
detected simultaneously in the eyes of trachoma patients in Nepal. Moreover, C. suis was isolated from
ocular and rectal samples originating from slaughterhouse workers and pig farmers [20–23]. The use of
sub-inhibitory concentrations of tetracycline, especially in the presence of tetracycline-resistant C. suis
isolates, could lead to treatment failure and the selection of tetracycline resistance on herd-level with
the potential recurrence of clinical signs [24,25]. However, despite the evidence for C. suis tetracycline
resistance, the treatment of chlamydiosis in pigs is still limited to tetracyclines [15].
2. Case Study
The need for ethics approval in this case is deemed unnecessary according to national Austrian
regulations (Tiergesundheitsdienstverordnung 2009, BGBl. II Nr. 434/2009), because data had been
collected during routine diagnostic measures within the herd health management.
The case herd was located in Lower Austria in a family-owned farrow-to-finish farm housing
60 sows and 350 fattening pigs. In 2017, an increase of the irregular return to estrus rate over the
last year, from 10% to more than 25% on average, was recorded. Sows of all parities were involved.
About 20% of sows in estrus had a yellowish mucous vaginal discharge. Since then, oxytetracycline
at an inconsistent concentration was fed during each estrus period for around five days, without
any improvement. Abortions were not recorded. Conjunctivitis was not observed in sows, but in
the fattening unit approximately 10% of the oldest finishers (19 and 22 weeks of age) showed severe
reddening of the conjunctiva, prolapse of the third eyelid, and seromucous ocular discharge. No other
clinical signs (e.g., fever, coughing, wasting, or diarrhea) were noted. Disinfection of the barns was not
performed on a routine basis.
Due to the clinical signs, the veterinarian suspected Chlamydia spp. to be the causative agent of
conjunctivitis in the finishers, which was confirmed by molecular and culture methods: in four out of
five conjunctival swabs, a Chlamydiales-specific real-time PCR targeting a fragment of about 207–215 bp
of the 16S rRNA region developed by Lienard [26], yielded positive results. Subsequent Sanger
sequencing of purified PCR products (200 bp amplicon of the 16S gene) [26] was performed, and the
sequences were compared against the National Center for Biotechnology Information (NCBI) database
using BLAST-n, categorized according to the first 16S rRNA BLAST-hit identification, and the closest
known organism found was C. suis (100% nucleotide identity). Furthermore, C. suis was successfully
isolated from all four swabs following inoculation onto LLC-MK2 cells (rhesus monkey kidney cells).
The species identity was then confirmed using established NAATs, a Chlamydiaceae-specific real-time
PCR targeting a 111 bp sequence of the 23S rRNA [27], followed by species-identification using an
Arraymate microarray [28,29], a method that can detect mixed infections with other chlamydiae [27,30].
Despite these findings, C. suis investigation of vaginal and cervical swabs taken from sows with vaginal
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discharge remained negative, but C. suis DNA was identified by PCR in the urogenital tract of one sow
slaughtered due to irregular return to estrus [31], though isolation attempts remained unsuccessful.
Subsequently, the herd veterinarian started whole-herd treatment with oxytetracycline (40 mg/kg
body weight/q 24 h) over 21 days, as in-feed medication. Additional improvements of biosecurity
measures, mainly focusing on cleaning and disinfection, were put in place. Signs of conjunctivitis
disappeared and fertility problems were reduced (less than 10 percent return to estrus rates, no vaginal
discharge). Three months later, the farmer reported new cases of conjunctivitis in six pigs. At the same
time, the fertility problems insidiously reoccurred. This time, fattening pigs were no longer treated,
while sow treatment over the insemination time was continued.
Due to the recurrence of clinical signs, retrospectively, further investigations regarding the
molecular characterization of the retained isolates taken at the first herd visit, prior to the antimicrobial
treatment by C. suis-specific multilocus sequence typing (MLST) [32] and antimicrobial susceptibility
testing [19], were performed (Table 1).
Table 1. Summary of characteristics of ocular C. suis isolates 1–4.
Isolate 1 Isolate 2 Isolate 3 Isolate 4
fattening ID 494 MS 490 MS 329 MS 330 MS
sequence type ST279 ST278 ST277 ST276
phylogenetic clade 1. clade 2. clade 2. clade 2. clade
Following MLST, the isolates were denoted with new distinct sequence types (STs: ST 276 for
isolate 330 MS, ST 277 for isolate 329 MS, ST278 for isolate 490 MS, and ST279 for isolate 494 MS), and the
phylogenetic analyses clustered the isolates into two genetically distinct clades (Figure 1). The 494 MS
isolate clustered in the first major clade together with other Swiss and US isolates [33,34], along with
type strain S45, which was isolated in Austria in the 1960s [33]. The other three isolates clustered in the
genetically diverse second major clade, which included other European, US, and Chinese C. suis pig
isolates. The 490 MS, 329 MS, and 330 MS isolates also formed a distinct well-supported subclade. MS
is the abbreviation for “fattening pig” in german.
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Figure 1. The mid-point rooted approximately-maximum-likelihood phylogenetic tree constructed
using an alignment of concatenated multilocus sequence typing (MLST) sequences from the four
isolates from this study, and an additional ten European, four US, and twenty-six Chinese C. suis
isolates. The support values are displayed on the nodes. The isolates from this study are denoted in
bold and red letters, other European strains in black, US strains in blue, and Chinese strains in green.
ST for each is denoted at the end of the strain name. The figure was created in Geneious Prime v.2019.1,
Biomatters (www.geneious.com).
For tetracycline and doxycycline susceptibility testing, all isolates were further tested for the
presence of the tetA(C) resistance gene by a PCR assay established by Dugan et al. using the primer
pair CS43/CS47 [17]. Two isolates (329 MS and 494 MS) were tetA(C)-positive, whereas the other two
were (330 MS, 490 MS) negative. To verify the resistance of C. suis to tetracycline and doxycycline,
the minimum inhibitory concentration (MIC) of tetracycline and doxycycline for all four isolates was
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determined as previously described [19]. The resulting consensus MIC was based on three values: First,
the MIC value resulting from “initial phenotype” testing, which was based on a fast screening method
developed by Marti et al. [19], where 96-well plates were simultaneously seeded and infected onto
serial dilutions of the antibiotic of choice, and where the MIC was defined as the first concentration
where the number of inclusions was strongly reduced compared to the control. Second, the value
obtained through the method described by Suchland et al. [20], who defined the MIC as, “two times
the concentration where over 90% of all inclusions were altered in size and morphology” compared to
the control, and third, the MIC was determined according to Donati et al. [35], who defined the MIC as,
“the lowest concentration that reduced the number of inclusions more than 90% compared to the level
of drug-free controls” (Table 2a,b). A consensus MIC is necessary, because small discrepancies (2-fold
differences) between assays are considered within the expected variations of these in vitro assays [19].
Table 2. (a) Susceptibility testing of tetracycline in vitro according to Marti et al. [19], and
(b) susceptibility testing of doxycycline in vitro according to Marti et al. [19]. MIC: Minimum
inhibitory concnetration.
(a)
MIC (µg/mL) 329 MS 330 MS 490 MS 494 MS
Initial phenotype 2 to 4 0.125 0.125 4
MIC (Suchland) 4 0.06 0.125 4
MIC (Donati) 4 0.06 0.125 4
MIC (consensus) 4 0.06–0.125 0.125 4
Interpretation resistant sensitive sensitive Resistant
(b)
MIC (µg/mL) 329 MS 330 MS 490 MS 494 MS
Initial phenotype 0.25 0.03–0.06 0.06 0.125
MIC (Suchland) 0.5 0.06 0.06 0.25
MIC (Donati) 0.25 0.06 0.06–0.125 0.25
MIC (consensus) 0.25–0.5 0.06 0.06 0.125–0.25
Interpretation Reduced susceptibility sensitive sensitive Reduced susceptibility
TetA(C)-positive isolates (TcR), 329 MS and 494 MS, had high MIC values (4 µg/mL) against
tetracycline (resistant if ≥4 µg/mL [35,36]) and were therefore confirmed to be resistant to tetracycline
in vitro, while the MICs of tetA(C)-negative isolates (TcS), 330 MS and 490 MS, had MICs ranging
from 0.06 to 0.125 µg/mL and were thus considered to be tetracycline sensitive. In contrast, no isolate
showed in vitro resistance to doxycycline, although the MICs of TcR isolates were two- to eight-fold
higher than those of TcS isolates (0.125–0.5 µg/mL compared to 0.06 µg/mL).
A recovery assay according to Marti et al. [18] was performed to determine the recovery from
single-dose treatment with either tetracycline or doxycycline (Figure 2a,b). Briefly, all four isolates
were exposed to low, moderate, and high concentrations of tetracycline (0.125, 0.5, and 2 µg/mL)
or doxycycline (0.015, 0.06, and 0.25 µg/mL). After 48 h, the supernatant was either replaced with
antibiotic-free (recovery, rec) or antibiotic-containing medium (continued exposure, exp), and incubated
for another 48 h before samples were collected to infect fresh monolayers to measure the inclusion
forming units per mL (IFU/mL).
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Figure 2. (a) Tetracycline recovery assay, and (b) doxycycline recovery assay according to Marti et al. [19].
X-axis: concentration of antimicrobials, y-axis: bars showing the number of viable elementary bodies
EBs. Each recovery assay was performed once with two technical replicates. PC: positive control, rec:
recovery group, exp: continuously exposed group.
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The recovery assay confirmed the MIC results of tetracycline with markedly better recovery for
the two TcR isolates (329 MS and 494 MS) compared to the TcS isolates (330 MS and 490 MS). Moreover,
while doxycycline resistance could not be confirmed for certain isolates (MIC ≤ 4 µg/mL [37]), both
MIC determination and the recovery assay indicate that the susceptibility of the TcR isolates was
reduced compared to the TcS isolates.
3. Conclusions
We detected genetically diverse C. suis isolates in the herd described in this case report. Genetic
diversity is consistent with previous studies [38–40], depicting the unprecedented diversity of the C.
suis genome compared to other chlamydial species, which is strongly influenced by recombination and
plasmid exchange. A broad diversity of isolates circulates within Europe, even within individual farms
or within the same animal [39]. Together with studies from the USA, Switzerland, Japan, and China,
this present case report on Austrian fattening pigs further illustrates a consistent diversity on a global
level rather than regional clustering, even though C. suis is genetically quite diverse. This diversity has
also been observed for other veterinary chlamydial species such as C. pecorum and C. psittaci [30,39,40].
While C. suis DNA was detected in the uterus of a slaughtered sow, fecal contamination during
the slaughtering process could not be excluded. Difficulties in detecting Chlamydia in sows with
reproductive failure are a common issue for veterinarians, who often decide to treat the sows with
antibiotics regardless of the molecular findings, a strategy that was also employed in this case.
The ocular C. suis isolates were not only genetically different but also either resistant or sensitive to
tetracyclines. Interestingly, both tetracycline sensitive and resistant isolates were isolated from animals
that lived in the same pen, and were therefore in regular physical contact with each other during the
study period, which coincides with the findings of a study investigating Swiss fattening pigs [36,39].
It could be hypothesized that resistance originates from the continued short-time application of
oxytetracycline in sows at the time of insemination. The necessity of antimicrobial treatment as
performed here, especially before valid susceptibility testing, is questionable, and should be viewed
critically. However, it is performed in many herds where Chlamydia spp. are suspected to be involved
in the fertility problems and are often the only possible choice due to the lack of anti-C. suis vaccines
on the market.
A striking observation was the fact that both tetA(C)-positive isolates (329 MS and 494 MS) were
tetracycline-resistant, but they only displayed decreased susceptibility to doxycycline in vitro compared
to the two tetA(C)-negative, tetracycline and doxycycline sensitive isolates (330 MS and 490 MS). These
findings stand in contrast to published results of Di Francesco et al., who concluded that the presence
of a tetA(C)-containing genomic island is linked to both tetracycline and doxycycline resistance, but
the findings are in line with another study from Germany [41]. The contrasting resistance in these two
antibiotics could be explained by differences in terms of pharmacodynamics and pharmacokinetics
between tetracyclines as a natural tetracycline, and doxycycline as a synthetic tetracycline [42].
The regular use of oxytetracycline, which is closer related to tetracycline than to doxycycline, in this
herd over years could be a possible explanation for the differences in resistance between tetracycline
and doxycycline. However, further studies are needed to investigate this phenomenon.
To estimate the resistance situation for Chlamydia, i.e., to confirm tetracycline resistance in C.
suis, isolation and antibiotic susceptibility testing must be performed in addition to the detection of
the tetA(C) gene by PCR, as there can be discrepancies between tetA(C) PCR results of clinical swab
samples and in vitro testing for tetracycline resistance [36]. In this study, however, such discrepancies
were not observed, giving a clear indication that the identified tetA(C) gene was part of C. suis and did
not originate from another bacterial species.
As a final conclusion to this study, we propose to establish chlamydial cultivation as part of routine
diagnostics in pigs for three reasons: First, infections with TcR C. suis isolates in the pork industry are
rising [43–46], which could complicate the treatment of porcine chlamydiosis, and might even pose
a threat for public health considering that transmission of C. suis to humans has been reported [36].
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Second, TcR isolates cannot be conclusively identified without cultivation, because, while current
molecular techniques may identify the tetA(C) gene, they cannot determine whether it originates
from C. suis or another bacterial species. Finally, taking together the increasing number of TcR C.
suis isolates and the inability to characterize them outside of in vitro assays, it is crucial to establish
routine cultivation procedures in order to predict the clinical impact that TcR C. suis isolates may have
on porcine health, a highly relevant question that has gained little attention so far, apart from case
studies [44].
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